The Black Health Block Quit and Screen Project
Launched by UNIVERSITY OF ARKANSAS · Apr 1, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Black Health Block Quit and Screen Project is a study aimed at helping Black health care providers assist Black smokers in quitting tobacco, including menthol cigarettes and flavored cigars. The project also focuses on early lung cancer screening to address health disparities in chronic diseases. The trial will test two different training programs to see which one better improves healthcare providers' knowledge and attitudes about advising patients to quit smoking and referring them for lung cancer screenings using a specific type of scan.
To participate in this study, healthcare providers must be a member of the National Medical Association, work with Black patients who smoke, and spend at least one day a week providing clinical care. They should also already be screening patients for tobacco use and be willing to refer smokers to a support navigator. Participants will complete training modules and take tests before and after the training to measure any changes in their knowledge and attitudes. This trial is not yet recruiting participants, but it aims to make a positive impact on the health of the community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Current National Medical Association (NMA) member
- • Serves a Black patient clientele who smokes
- • At least 20% of time (1 day per week) devoted to clinical care
- • Currently screens clients for tobacco use in the clinic
- • Have the capacity to refer smokers to a patient navigator
- • Willing to provide informed consent
- • Will provide contact email, address and phone.
- Exclusion Criteria:
- • None
About University Of Arkansas
The University of Arkansas is a leading research institution dedicated to advancing healthcare through innovative clinical trials. With a commitment to excellence in research and education, the university facilitates a collaborative environment that encourages interdisciplinary studies and the development of cutting-edge therapies. Its clinical trial programs leverage state-of-the-art facilities and expert faculty, aiming to improve patient outcomes and contribute to the body of medical knowledge. The university fosters partnerships with healthcare providers and industry stakeholders, ensuring rigorous ethical standards and adherence to regulatory requirements in all research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Richmond, Virginia, United States
Patients applied
Trial Officials
Pebbles Fagan, PhD, MPH
Principal Investigator
University of Arkansas
Mignonne Guy, PhD
Principal Investigator
Virginia Commonwealth University
Ashley Clawson, PhD
Principal Investigator
University of Arkansas
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported